Ocular Therapeutix Inc (OCUL)
6.17
+0.30
(+5.11%)
USD |
NASDAQ |
May 03, 16:00
6.16
-0.01
(-0.16%)
After-Hours: 20:00
Ocular Therapeutix Accounts Payable (Quarterly): 4.389M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.389M |
September 30, 2023 | 3.984M |
June 30, 2023 | 3.572M |
March 31, 2023 | 5.441M |
December 31, 2022 | 5.123M |
September 30, 2022 | 5.308M |
June 30, 2022 | 3.703M |
March 31, 2022 | 3.42M |
December 31, 2021 | 4.592M |
September 30, 2021 | 4.246M |
June 30, 2021 | 3.881M |
March 31, 2021 | 4.152M |
December 31, 2020 | 2.709M |
September 30, 2020 | 3.238M |
June 30, 2020 | 2.65M |
March 31, 2020 | 2.839M |
December 31, 2019 | 3.268M |
September 30, 2019 | 3.461M |
June 30, 2019 | 4.044M |
March 31, 2019 | 3.902M |
December 31, 2018 | 2.965M |
Date | Value |
---|---|
September 30, 2018 | 2.777M |
June 30, 2018 | 2.137M |
March 31, 2018 | 3.477M |
December 31, 2017 | 3.571M |
September 30, 2017 | 2.599M |
June 30, 2017 | 6.307M |
March 31, 2017 | 3.754M |
December 31, 2016 | 2.116M |
September 30, 2016 | 1.68M |
June 30, 2016 | 1.611M |
March 31, 2016 | 2.063M |
December 31, 2015 | 1.957M |
September 30, 2015 | 1.624M |
June 30, 2015 | 2.812M |
March 31, 2015 | 2.195M |
December 31, 2014 | 1.316M |
September 30, 2014 | 0.649M |
June 30, 2014 | 1.525M |
March 31, 2014 | 0.996M |
December 31, 2013 | 0.545M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.65M
Minimum
Jun 2020
5.441M
Maximum
Mar 2023
3.896M
Average
3.881M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
Amgen Inc | 1.628B |
Assertio Holdings Inc | 13.44M |
CytomX Therapeutics Inc | 1.458M |
EyePoint Pharmaceuticals Inc | 6.504M |
Regeneron Pharmaceuticals Inc | 671.30M |